Warning! GuruFocus detected
2 Severe warning signs
with WF6.
Try a 7-Day Free Trial
to check it out.
What is a stock summary page? Click here for an overview.
Business Description
MindBio Therapeutics Corp
NAICS : 541714
SIC : 3741
ISIN : CA60256C1086
Description
MindBio Therapeutics Corp is engaged in the research, development, and testing of psychedelic substances as a potential treatment for the management of a broad range of mental health conditions. The company invests in clinical research to discover potential new treatment options and aims to create novel medicines and treatment regimes from breakthrough micro dosing studies. Geographically, the company's activities take place in Australia.
Financial Strength
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 0.02 | |||||
Equity-to-Asset | -41.28 | |||||
Debt-to-Equity | -0.86 | |||||
Debt-to-EBITDA | -151.8 | |||||
Piotroski F-Score | 2/9 | |||||
Altman Z-Score | -181.62 | |||||
WACC vs ROIC |
Growth Rank
Name | Current | Vs Industry | Vs History |
---|
Momentum Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 4.42 | |||||
9-Day RSI | 20.85 | |||||
14-Day RSI | 33.96 | |||||
3-1 Month Momentum % | -68.57 | |||||
6-1 Month Momentum % | -71.05 | |||||
12-1 Month Momentum % | -92.67 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 0.02 | |||||
Quick Ratio | 0.02 | |||||
Cash Ratio | 0.01 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Shareholder Yield % | -24.85 |
Profitability Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Operating Margin % | 91.58 | |||||
Net Margin % | 293.16 | |||||
FCF Margin % | 49.22 | |||||
ROA % | -341.3 | |||||
ROIC % | -5.6 |
GF Value Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
EV-to-EBIT | -37.99 | |||||
EV-to-EBITDA | -186.17 | |||||
EV-to-Revenue | -29.39 | |||||
EV-to-FCF | -53.59 | |||||
Earnings Yield (Greenblatt) % | -2.63 | |||||
FCF Yield % | -6.69 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
MindBio Therapeutics Corp Executives
DetailsGF Value
Analyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil €) | -0.128 | ||
EPS (TTM) (€) | -0.003 | ||
Beta | - | ||
3-Year Sharpe Ratio | - | ||
3-Year Sortino Ratio | - | ||
Volatility % | 240.56 | ||
14-Day RSI | 33.96 | ||
14-Day ATR (€) | 0.000849 | ||
20-Day SMA (€) | 0.00522 | ||
12-1 Month Momentum % | -92.67 | ||
52-Week Range (€) | 0.0004 - 0.044 | ||
Shares Outstanding (Mil) | 142.96 |
Piotroski F-Score Details
Year:
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 2 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
MindBio Therapeutics Corp Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
MindBio Therapeutics Corp Stock Events
Event | Date | Price (€) | ||
---|---|---|---|---|
No Event Data |
MindBio Therapeutics Corp Frequently Asked Questions
What is MindBio Therapeutics Corp(FRA:WF6)'s stock price today?
The current price of FRA:WF6 is €0.00. The 52 week high of FRA:WF6 is €0.04 and 52 week low is €0.00.
When is next earnings date of MindBio Therapeutics Corp(FRA:WF6)?
The next earnings date of MindBio Therapeutics Corp(FRA:WF6) is .
Does MindBio Therapeutics Corp(FRA:WF6) pay dividends? If so, how much?
MindBio Therapeutics Corp(FRA:WF6) does not pay dividend.
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |